121 related articles for article (PubMed ID: 9760451)
1. Genetic polymorphism of conjugating enzymes and cancer risk: GSTM1, GSTT1, NAT1 and NAT2.
Lee E; Huang Y; Zhao B; Seow-Choen F; Balakrishnan A; Chan SH
J Toxicol Sci; 1998 Jul; 23 Suppl 2():140-2. PubMed ID: 9760451
[No Abstract] [Full Text] [Related]
2. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer.
Kiss I; Németh A; Bogner B; Pajkos G; Orsós Z; Sándor J; Csejtey A; Faluhelyi Z; Rodler I; Ember I
Anticancer Res; 2004; 24(6):3965-70. PubMed ID: 15736440
[TBL] [Abstract][Full Text] [Related]
3. No association between genetic polymorphisms of CYP1A1, GSTM1, GSTT1, GSTP1, NAT2, and nasopharyngeal carcinoma in Taiwan.
Cheng YJ; Chien YC; Hildesheim A; Hsu MM; Chen IH; Chuang J; Chang J; Ma YD; Luo CT; Hsu WL; Hsu HH; Huang H; Chang JF; Chen CJ; Yang CS
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):179-80. PubMed ID: 12582034
[No Abstract] [Full Text] [Related]
4. No modifying effect of NAT1, GSTM1, and GSTT1 on the relation between smoking and colorectal cancer risk.
van der Hel OL; Bueno de Mesquita HB; Roest M; Slothouber B; van Gils C; van Noord PA; Grobbee DE; Peeters PH
Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):681-2. PubMed ID: 12869413
[No Abstract] [Full Text] [Related]
5. [Genetic polymorphism of gluthation-S transferases and N-acetyl transferases 2 and nasopharyngeal carcinoma: the Tunisia experience].
Bendjemana K; Abdennebi M; Gara S; Jmal A; Ghanem A; Touati S; Boussen H; Ladgham A; Guemira F
Bull Cancer; 2006 Mar; 93(3):297-302. PubMed ID: 16567317
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in GSTP1, GSTM1, and GSTT1 and susceptibility to colorectal cancer.
Welfare M; Monesola Adeokun A; Bassendine MF; Daly AK
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):289-92. PubMed ID: 10207630
[TBL] [Abstract][Full Text] [Related]
7. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer.
Bell DA; Stephens EA; Castranio T; Umbach DM; Watson M; Deakin M; Elder J; Hendrickse C; Duncan H; Strange RC
Cancer Res; 1995 Aug; 55(16):3537-42. PubMed ID: 7627961
[TBL] [Abstract][Full Text] [Related]
8. Modulation of DNA and protein adducts in smokers by genetic polymorphisms in GSTM1,GSTT1, NAT1 and NAT2.
Godschalk RW; Dallinga JW; Wikman H; Risch A; Kleinjans JC; Bartsch H; Van Schooten FJ
Pharmacogenetics; 2001 Jul; 11(5):389-98. PubMed ID: 11470992
[TBL] [Abstract][Full Text] [Related]
9. Impact of GSTT1, GSTM1, GSTP1 and NAT2 genotypes on KRAS2 and TP53 gene mutations in colorectal cancer.
Ferraz JM; Zinzindohoué F; Lecomte T; Cugnenc PH; Loriot MA; Beaune P; Stücker I; Berger A; Laurent-Puig P
Int J Cancer; 2004 Jun; 110(2):183-7. PubMed ID: 15069679
[TBL] [Abstract][Full Text] [Related]
10. Glutathione S-transferase GSTM1 and GSTT1 polymorphisms and colorectal cancer risk: a prospective study.
Gertig DM; Stampfer M; Haiman C; Hennekens CH; Kelsey K; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1001-5. PubMed ID: 9829708
[TBL] [Abstract][Full Text] [Related]
11. N-acetyltransferase (NAT1, NAT2) and glutathione S-transferase (GSTM1, GSTT1) polymorphisms in breast cancer.
Lee KM; Park SK; Kim SU; Doll MA; Yoo KY; Ahn SH; Noh DY; Hirvonen A; Hein DW; Kang D
Cancer Lett; 2003 Jul; 196(2):179-86. PubMed ID: 12860276
[TBL] [Abstract][Full Text] [Related]
12. GSTM1, GSTT1, and GSTP1 polymorphisms and risk of advanced colorectal adenoma.
Moore LE; Huang WY; Chatterjee N; Gunter M; Chanock S; Yeager M; Welch B; Pinsky P; Weissfeld J; Hayes RB
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1823-7. PubMed ID: 16030123
[TBL] [Abstract][Full Text] [Related]
13. GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer.
Olshan AF; Weissler MC; Watson MA; Bell DA
Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):185-91. PubMed ID: 10698480
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.
Salagovic J; Kalina I; Stubna J; Habalová V; Hrivnák M; Valanský L; Kohút A; Biros E
Neoplasma; 1998; 45(5):312-7. PubMed ID: 9921921
[TBL] [Abstract][Full Text] [Related]
15. Relationship between metabolic enzyme polymorphism and colorectal cancer.
Chen K; Jiang QT; He HQ
World J Gastroenterol; 2005 Jan; 11(3):331-5. PubMed ID: 15637738
[TBL] [Abstract][Full Text] [Related]
16. The role of N-acetyltransferase-2 and glutathione S-transferase on the risk and aggressiveness of bladder cancer.
Giannakopoulos X; Charalabopoulos K; Baltogiannis D; Chatzikiriakidou A; Alamanos Y; Georgiou I; Evangelou A; Agnantis N; Sofikitis N
Anticancer Res; 2002; 22(6B):3801-4. PubMed ID: 12552997
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism of glutathione S-transferase genes (GSTM1, GSTT1 and GSTP1) and susceptibility to prostate cancer in Northern India.
Srivastava DS; Mandhani A; Mittal B; Mittal RD
BJU Int; 2005 Jan; 95(1):170-3. PubMed ID: 15638917
[TBL] [Abstract][Full Text] [Related]
18. Arylamine N-acetyltransferase type 2 and glutathione S-transferases M1 and T1 polymorphisms in familial adenomatous polyposis.
Lamberti C; Jungck M; Laarmann M; Knapp M; Caspari R; Friedl W; Sauerbruch T; Propping P; Kruse R
Pharmacogenetics; 2002 Jan; 12(1):49-54. PubMed ID: 11773864
[TBL] [Abstract][Full Text] [Related]
19. N-acetyl transferase 1: two polymorphisms in coding sequence identified in colorectal cancer patients.
Hubbard AL; Moyes C; Wyllie AH; Smith CA; Harrison DJ
Br J Cancer; 1998 Mar; 77(6):913-6. PubMed ID: 9528834
[TBL] [Abstract][Full Text] [Related]
20. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer.
Sachse C; Smith G; Wilkie MJ; Barrett JH; Waxman R; Sullivan F; Forman D; Bishop DT; Wolf CR;
Carcinogenesis; 2002 Nov; 23(11):1839-49. PubMed ID: 12419832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
